INmune Bio (INMB) to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th
Go back to INmune Bio (INMB) to Announce Top Line Results from MINDFuL Phase 2 Trial in Early Alzheimer’s on Monday, June 30th| (NASDAQ: INMB) | Delayed: 2.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.44 | 52 Week High | $ | |||
| Open | $2.44 | 52 Week Low | $ | |||
| Day High | $2.44 | P/E | N/A | |||
| Day Low | $2.44 | EPS | $ | |||
| Volume | 3,481 | |||||

